AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVA EYE MEDICAL LTD

0.105

+0.0066.06%

Volume:387.19K

Turnover:40.68K

Market Cap:29.83M

PE:-2.74

High:0.110

Open:0.110

Low:0.105

Close:0.099

Loading ...

Overview Company News Filings

BUZZ-Australia's Nova Eye Medical jumps on Q3 sales surge

BRIEF-Nova Eye Medical Posts Q3 Sales Of $4.7 Mln

Nova Eye Medical Ltd - Q3FY25 Sales of US$4.7 Mln, up 27% on Pcp

THOMSON REUTERS

Nova Eye Medical Limited (ASX:EYE) Stock's 30% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Simply Wall St.

National Vision Holdings Appoints Christopher Laden as CFO

MT Newswires Live

BRIEF-Nova Eye Medical HY Net Loss Attributable A$5.4 Million

Nova Eye Medical Ltd - Hy Revenues From Ordinary Activities a$12.9 Mln

THOMSON REUTERS

BRIEF-Nova Eye Medical Announces A$6.6 Million Placement

BRIEF-Nova Eye Medical Sees FY Revenue Between A$27.5 Mln And A$29.1 Mln

Nova Eye Medical Ltd - Full-Year Revenue Projected Between a$27.5 Mln and a$29.1 Mln

THOMSON REUTERS

BRIEF-Nova Eye Medical Seeks Trading Halt

Nova Eye Medical - Seeks Trading Halt Pending Announcement on Proposed Capital Raising

THOMSON REUTERS

Mueller Water Products Appoints Melissa Rasmussen as CFO

MT Newswires Live

Nova Eye Medical Limited (ASX:EYE) Stock Rockets 29% But Many Are Still Ignoring The Company

Simply Wall St.

Nova Eye Medical Limited's (ASX:EYE) Shift From Loss To Profit

Simply Wall St.

We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EYE.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EYE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","market":"AU","secType":"STK","nameCN":"NOVA EYE MEDICAL LTD","latestPrice":0.105,"timestamp":1745907120000,"preClose":0.099,"halted":0,"volume":387190,"delay":0,"nameEN":"NOVA EYE MEDICAL LTD","floatShares":240468804,"shares":284079764,"eps":-0.038321,"marketStatus":"Closed","change":0.006,"latestTime":"04-29 16:12:00 AEST","open":0.11,"high":0.11,"low":0.105,"amount":40681,"amplitude":0.050505,"askPrice":0.105,"askSize":83731,"bidPrice":0.1,"bidSize":165000,"shortable":3,"etf":0,"ttmEps":-0.038321,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745971200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.099,"openAndCloseTimeList":[[1745884800000,1745906400000]],"volumeRatio":1.742951,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYE.AU\",,,,,undefined,":{"symbol":"EYE.AU","floatShares":240468804,"roa":"-21.93%","roe":"-49.77%","lyrEps":-0.043058,"volumeRatio":1.742951,"shares":284079764,"dividePrice":0,"high":0.11,"amplitude":0.050505,"preClose":0.099,"low":0.105,"week52Low":0.086,"pbRate":"1.72","psRate":"1.14","week52High":0.3,"institutionHeld":0,"latestPrice":0.105,"committee":0.326735,"eps":-0.038321,"divideRate":0,"volume":387190,"delay":0,"ttmEps":-0.038321,"open":0.11,"prevYearClose":0.16,"prevWeekClose":0.1,"prevMonthClose":0.1,"prevQuarterClose":0.1,"fiveDayClose":0.105,"twentyDayClose":0.094,"sixtyDayClose":0.165},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYE.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531624114","title":"BUZZ-Australia's Nova Eye Medical jumps on Q3 sales surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2531624114","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531624114?lang=en_us&edition=fundamental","pubTime":"2025-04-29 12:31","pubTimestamp":1745901091,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Nova Eye Medical jumps on Q3 sales surge** Nova Eye Medical EYE.AX jumps as much as 11.1% to A$0.110; set for biggest intraday pct gain since April 10** Medical technology provider's Q3 sales rises 27% y/y** Q3 U.S. sales jumps 32% y/y, marking its highest ever sales** EYE last up 6.1%; trims YTD losses to 34.4%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4N3R7095:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU"],"gpt_icon":0},{"id":"2531215417","title":"BRIEF-Nova Eye Medical Posts Q3 Sales Of $4.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2531215417","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531215417?lang=en_us&edition=fundamental","pubTime":"2025-04-29 09:40","pubTimestamp":1745890820,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Posts Q3 Sales Of $4.7 MlnApril 29 (Reuters) - Nova Eye Medical Ltd EYE.AX:Q3FY25 SALES OF US$4.7 MILLION, UP 27% ON PCPFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU"],"gpt_icon":0},{"id":"2531299060","title":"Nova Eye Medical Ltd - Q3FY25 Sales of US$4.7 Mln, up 27% on Pcp","url":"https://stock-news.laohu8.com/highlight/detail?id=2531299060","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531299060?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:59","pubTimestamp":1745884785,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R62KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2517908709","title":"Nova Eye Medical Limited (ASX:EYE) Stock's 30% Dive Might Signal An Opportunity But It Requires Some Scrutiny","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908709","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517908709?lang=en_us&edition=fundamental","pubTime":"2025-03-06 04:10","pubTimestamp":1741205419,"startTime":"0","endTime":"0","summary":"Nova Eye Medical Limited ( ASX:EYE ) shareholders that were waiting for something to happen have been dealt a blow with...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/nova-eye-medical-limited-asxeye-stocks-30-dive-might-signal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ELXMF","EYE.AU","BK4200","BK7007","LU0566484027.USD","BK4082","LU0053671581.USD","LU1559883803.SGD","EYE"],"gpt_icon":0},{"id":"2514835908","title":"National Vision Holdings Appoints Christopher Laden as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2514835908","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514835908?lang=en_us&edition=fundamental","pubTime":"2025-02-26 19:31","pubTimestamp":1740569515,"startTime":"0","endTime":"0","summary":"National Vision Holdings  said Wednesday that it has appointed Christopher Laden as chief financial officer, effective March 31.Laden most recently served as CFO of Community Veterinary Partners, before which he was the CFO for Women's Care and MD Now Urgent Care.He will succeed Melissa Rasmussen who will step down from the company, effective March 3.Patrick Moore, who serves as a special advisor to National Vision, will assume the role of interim CFO effective March 4.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EYE","LU0566484027.USD","BK7007","EYE.AU","BK4200","LU0053671581.USD","LU1559883803.SGD"],"gpt_icon":0},{"id":"2514119022","title":"BRIEF-Nova Eye Medical HY Net Loss Attributable A$5.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514119022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514119022?lang=en_us&edition=fundamental","pubTime":"2025-02-26 09:33","pubTimestamp":1740533592,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical HY Net Loss Attributable A$5.4 MillionFeb 26 (Reuters) - Nova Eye Medical Ltd EYE.AX:HY REVENUES FROM ORDINARY ACTIVITIES A$12.9 MILLIONHY NET LOSS ATTRIBUTABLE A$5.4 MILLIONFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2514478047","title":"Nova Eye Medical Ltd -  Hy Revenues From Ordinary Activities a$12.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514478047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514478047?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:13","pubTimestamp":1740521597,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2507983489","title":"BRIEF-Nova Eye Medical Announces A$6.6 Million Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2507983489","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507983489?lang=en_us&edition=fundamental","pubTime":"2025-01-31 09:35","pubTimestamp":1738287311,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Announces A$6.6 Million PlacementJan 31 (Reuters) - Nova Eye Medical Ltd EYE.AX:A$6.6 MILLION PLACEMENT AT A$0.12 PER NEW SHAREFY25 REVENUE GUIDANCE (EXCLUDING CHINA SALES) OF US$9-10 MILLION FOR H2Further company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OQ1WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2507998381","title":"BRIEF-Nova Eye Medical Sees FY Revenue Between A$27.5 Mln And A$29.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2507998381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507998381?lang=en_us&edition=fundamental","pubTime":"2025-01-31 09:22","pubTimestamp":1738286526,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Sees FY Revenue Between A$27.5 Mln And A$29.1 MlnJan 31 (Reuters) - Nova Eye Medical Ltd EYE.AX:FULL-YEAR REVENUE PROJECTED BETWEEN A$27.5 MILLION AND A$29.1 MILLIONFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OQ24K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYE.AU"],"gpt_icon":0},{"id":"2507604965","title":"Nova Eye Medical Ltd - Full-Year Revenue Projected Between a$27.5 Mln and a$29.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2507604965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507604965?lang=en_us&edition=fundamental","pubTime":"2025-01-31 07:10","pubTimestamp":1738278645,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ24K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EYE.AU","BK7007"],"gpt_icon":0},{"id":"2507524027","title":"BRIEF-Nova Eye Medical Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2507524027","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507524027?lang=en_us&edition=fundamental","pubTime":"2025-01-29 06:26","pubTimestamp":1738103178,"startTime":"0","endTime":"0","summary":"BRIEF-Nova Eye Medical Seeks Trading HaltJan 29 (Reuters) - Nova Eye Medical Ltd EYE.AX:SEEKS  TRADING HALT PENDING ANNOUNCEMENT ON PROPOSED CAPITAL RAISINGFurther company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2507240675","title":"Nova Eye Medical - Seeks  Trading Halt Pending Announcement on Proposed Capital Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2507240675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507240675?lang=en_us&edition=fundamental","pubTime":"2025-01-29 06:25","pubTimestamp":1738103115,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","EYE.AU"],"gpt_icon":0},{"id":"2504925369","title":"Mueller Water Products Appoints Melissa Rasmussen as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2504925369","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504925369?lang=en_us&edition=fundamental","pubTime":"2025-01-17 05:49","pubTimestamp":1737064197,"startTime":"0","endTime":"0","summary":"Mueller Water Products (MWA) appointed Melissa Rasmussen as chief financial officer, effective March 4.Rasmussen, 48, has been CFO of National Vision Holdings (EYE) since January 2023, Muller Water said Thursday in a regulatory filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MWA","LU0053671581.USD","BK7007","LU1721427968.SGD","EYE","BK4161","LU1165135440.EUR","LU1559883803.SGD","MLI","EYE.AU","LU1543694498.USD","BK4200","LU0566484027.USD","BK4585"],"gpt_icon":0},{"id":"2502317013","title":"Nova Eye Medical Limited (ASX:EYE) Stock Rockets 29% But Many Are Still Ignoring The Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2502317013","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502317013?lang=en_us&edition=fundamental","pubTime":"2025-01-12 06:02","pubTimestamp":1736632954,"startTime":"0","endTime":"0","summary":"Nova Eye Medical Limited ( ASX:EYE ) shares have had a really impressive month, gaining 29% after a shaky period...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/nova-eye-medical-limited-asxeye-stock-rockets-29-but-many-ar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4200","LU1559883803.SGD","BK7007","EYE","BK4082","LU0053671581.USD","LU0566484027.USD","ELXMF","EYE.AU"],"gpt_icon":0},{"id":"2491313930","title":"Nova Eye Medical Limited's (ASX:EYE) Shift From Loss To Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2491313930","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491313930?lang=en_us&edition=fundamental","pubTime":"2024-12-13 08:33","pubTimestamp":1734050037,"startTime":"0","endTime":"0","summary":"We feel now is a pretty good time to analyse Nova Eye Medical Limited's ( ASX:EYE ) business as it appears the company...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/nova-eye-medical-limiteds-asxeye-shift-from-loss-to-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","LU1559883803.SGD","BK4082","EYE.AU","BK4200","ELXMF","EYE","LU0566484027.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2481590399","title":"We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2481590399","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481590399?lang=en_us&edition=fundamental","pubTime":"2024-11-05 05:27","pubTimestamp":1730755631,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-eye/nova-eye-medical-shares/news/we-think-nova-eye-medical-asxeye-can-afford-to-drive-busines","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EYE","BK4200","BK7007","EYE.AU","LU1559883803.SGD","LU0053671581.USD","LU0566484027.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYE.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-13","symbol":"EYE.AU","defaultRemindTime":1707778800000,"type":"split","dateTimestamp":1707742800000,"forFactor":973737,"toFactor":1000000,"ratio":0.973737},{"date":"2023-08-28","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null},{"date":"2023-02-27","symbol":"EYE.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677452400000,"name":null,"time":"","dateTimestamp":1677416400000,"actualEps":null},{"market":"AU","date":"2022-02-14","symbol":"EYE.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644757200000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2020-07-21","symbol":"EYE.AU","amount":0.135,"name":"Ellex Medical Lasers Ltd","recordDate":"2020-07-29","payableDate":"2020-07-22","currency":"AUD","type":"dividend","dateTimestamp":1595253600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-07-21","recordDate":"2020-07-22","paymentDate":"2020-07-29","value":0.135,"currency":"AUD"}]}}